El interés en corto de MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN. Los datos de interés en corto se actualizan cada dos semanas.

MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN (ARCA:OILU), Informe de interés en corto

The 3X ETNs provide levered exposure to the Index. The Index is a total return index that tracks the stock prices of large-capitalization companies that are domiciled and listed in the U.S. and that are active in the exploration and production of oil and gas. The 3X ETNs seek a return on the underlying index for a single day.

MicroSectors Oil & Gas Exploration & Production 3X Leveraged ETNs

UBS BBG CMCI WTI CRUDE IDX USD ETF

MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN

UBS FND SOL USD ETF

News

Guidance

Grocery Outlet Says It Is In The Process Of Reassessing Its Full Year Guidance; Expects To Exceed High End Of Net Sales Guidance Range Of $4.30B - $4.35B (Est 4.36B)

Shares of Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) rose sharply in today's pre-market trading after the company reported better-than-expected<a href="https://www.benzinga.com/news/earnings/24/10/41611263/alphabet-q3-earnings-highlights-revenue-beat-eps-beat-google-cloud-up-35-momentum-across-the-compan"> third-quarter financial results</a>.
The company reported third-quarter revenue of $88.27 billion, up 15% year-over-year. The total beat a Street consensus estimate of $86.31 billion
Alphabet shares jumped 6% to $179.77 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Haoxi Health Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) gained 82.8% to $0.3382 in pre-market trading. Haoxi Health Technology recently posted FY earnings of 4 cents per share.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) rose 80.2% to $0.2433 in pre-market trading.</li>
<li>Digital Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) shares surged 50.5% to $0.1540 in pre-market trading. Digital Brands Group shares fell around 34% on Tuesday after the company announced the pricing of $3 million public offering of 30 million common stock and pre-funded warrants at $0.10 per share.</li>
<li>Ensysce Biosciences, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) gained 30.8% to $0.5430 in pre-market trading after jumping around 25% on Tuesday.</li>
<li>NerdWallet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRDS#NASDAQ">NRDS</a>) shares rose 28.7% to $14.57 in pre-market trading after the company reported better-than-expected fourth-quarter revenue results.</li>
<li>LogicMark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) climbed 26.4% to $0.1464 in pre-market trading.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) gained 24% to $101.36 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Polyrizon Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares gained 20.7% to $1.87 in pre-market trading after dipping 65% on Tuesday. The company priced its IPO at $4.38 per unit.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) shares rose 11.2% to $12.11 in pre-market trading following better-than-expected third-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>O-I Glass, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) shares dipped 18.4% to $10.15 in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 adjusted EPS guidance below estimates.</li>
<li>Spero Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRO#NASDAQ">SPRO</a>) shares fell 18.3% to $1.07 in pre-market trading after the company announced its Phase 2a proof-of-concept study of SPR720 did not meet its primary endpoint.</li>
<li>Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares fell 18% to $82.40 in pre-market trading after the company reported issued weak guidance for the third quarter.</li>
<li>GlycoMimetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) fell 14.5% to $0.4189 in today's pre-market trading. GlycoMimetics shares jumped 191% on Tuesday after the company announced it will merge with Crescent Biopharma and secured $200 in funding to advance its oncology pipeline.</li>
<li>Thryv Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRY#NASDAQ">THRY</a>) fell 13.7% to $15.80 in pre-market trading after the company priced its upsized $80 million public offering of 5,715,000 common shares at $14/share.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) fell 12.3% to $0.9645 in pre-market trading. The company recently entered into an agreement with Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>) to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq) and bevacizumab, the current standard of care for unresectable or metastatic hepatocellular carcinoma (HCC), into a Phase 3 trial for the first-line treatment of liver cancer.</li>
<li>Ambow Education Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#NYSE">AMBO</a>) shares declined 12.3% to $1.50 in pre-market trading.</li>
<li>Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) declined 12.2% to $1.58 in pre-market trading as the company priced its $4.5 million public offering of 2,950,820 at-the-market under Nasdaq rules.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares fell 8.6% to $152.00 after the company reported third-quarter financial results.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) fell 8.4% to $47.17 in pre-market trading after gaining around 9% on Tuesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41599928/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-for-october">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio For October</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMBO

DBGI

ENSC

GLYC

GOOG

GOOGL

LGMK

NRDS

PLRZ

QRVO

RDDT

RHHBY

SHPH

SNAP

SPRO

STBX

THRY

Tempest Therapeutics, Inc. - Common Stock

TPST

Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

GigaMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) reported quarterly losses of $(0.03) per share. This is a 40 percent increase over losses of $(0.05) per share from the same period last year. The company reported $769.00 thousand in sales this quarter. This is a 28.20 percent decrease over sales of $1.07 million the same period last year.

Earnings

GIGM

GigaMedia Q3 GAAP EPS $(0.03) Up From $(0.05) YoY, Sales $769.00K Down From $1.07M YoY

This story was first published on the&nbsp;<a href="https://in.benzinga.com/markets/equities/24/10/41349626/much-appreciated-elon-musk-cheers-indias-move-to-allocate-satellite-spectrum" target="_blank">Benzinga India portal.</a>
In the fiscal year 2024, Amazon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) India units have witnessed moderate growth and have reduced their losses, according to a recent report.
What Happened: Amazon India&rsquo;s units have seen moderate growth and have significantly reduced their losses in the fiscal year 2024, the Economic Times reported. The company&rsquo;s arm, Amazon Transportation Services, saw its operating revenue increase 7.6% to ₹4,889 crore in FY24. It reduced its losses to ₹80 crore from ₹86 crore in the previous year.
Amazon Wholesale&rsquo;s operating revenue fell to ₹3,577 crore from ₹3,600 crore in the previous year. The wholesale unit had scaled back operations after regulations around foreign direct investments had been tightened for e-commerce companies owned by foreign firms. The arm&rsquo;s net loss reduced to ₹342 crore from ₹612 crore in FY23.
If you&rsquo;d like to be ahead&nbsp;of the curve on the Indian stock market, sign up for our Ring The Bell newsletter by&nbsp;<a href="https://share.hsforms.com/1K1H7Kd0aRhmSdDIuxTAkxg1npzh" rel="noopener noreferrer" target="_blank">clicking here</a>.
Amazon Pay&rsquo;s operating revenue went up to ₹2,286 crore in FY24 from ₹2,136 crore in FY23 while its net loss narrowed to ₹911 crore from ₹1,494 crore.
Amazon had invested ₹850 crores in FY23 and ₹600 crores in May into Amazon Pay to prepare it for competition against&nbsp;Paytm, PhonePe&nbsp;and&nbsp;Google Pay.
Amazon Pay had processed 7.09 crore UPI transactions as of September 2024 becoming the seventh largest UPI player in transaction volumes. PhonePe, Google Pay, Paytm, Cred, Navi and Axis Bank apps lead in terms of UPI volumes.
See Also:&nbsp;<a href="https://in.benzinga.com/markets/equities/24/10/41618168/zomato-or-swiggy-which-performed-better-in-lead-up-to-ipo" rel="noreferrer noopener" target="_blank">Zomato Or Swiggy? Which Performed Better In Lead-Up To IPO</a>
Disclaimer: Artificial intelligence was used as a secondary aid in the writing of this story.

Retail Sales

Tech

AMZN

Amazon India Units Trims Losses, Posts Moderate Revenue Growth In FY24

Biotech

Health Care

General

BCLI

Brainstorm Cell Therapeutics Received Written Notice From The Nasdaq Stock Market Stating That The Company Has Regained Compliance With The Minimum Closing Bid Price Requirement For Continued Listing

Quhuo Reported Strong Performance From Its Homestay Division During The National Day Holiday, With Average Daily GMV Up 123% And Peak Occupancy Reached 90% Of Available Rooms

Grocery Outlet Expects To Meet Previously Discussed Q3 Earnings Guidance; Expects Net Sales To Be $1.1B (Est $1.094B), Up 10.4% Y/Y, With Comparable Store Sales Increasing 1.2%

WIIM

OTIS

Otis Worldwide shares are trading lower after reporting worse-than-expected Q3 financial results and lowering annual outlook.

Financing

AKRO

Axonis Therapeutics Announced The Successful Completion Of An Oversubscribed $115M Series A Financing

Exane BNP Paribas analyst Karl Ackerman downgrades Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) from Outperform to Neutral and announces $80 price target.

Downgrades

Price Target

Analyst Ratings

Exane BNP Paribas Downgrades Qorvo to Neutral, Announces $80 Price Target

Kyocera (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KYOCY#OTC">KYOCY</a>) is looking for FY2025 GAAP EPS of $0.34. seessales of $13.570 billion.

KYOCY

Kyocera Sees FY2025 GAAP EPS JPY 50.40; Sees Sales JPY 2020B

Offerings

SJW Filed Prospectus Related To The Offer And Sale From Time To Time Of Shares Of Common Stock Having An Aggregate Gross Sales Price Of Up To $200M

2024 Outlook1
Otis is revising its full year outlook:
•Net sales of ~$14.2 billion
•Organic sales up ~1.5%
◦Organic New Equipment sales down mid to high single digits
◦Organic Service sales up ~6.5%
•Adjusted operating profit of ~$2.375 billion, up ~$140 million at constant currency; up ~$105 million at actual currency
•Adjusted EPS of ~$3.85, up ~9%; adjusted effective tax rate of approximately 25.0%
•Adjusted free cash flow of approximately $1.4 billion to $1.5 billion
 &nbsp;
1Note: When we provide outlook for organic sales, adjusted operating profit, adjusted effective tax rate and adjusted free cash flow on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and the corresponding GAAP measures generally is not available without unreasonable effort. See "Use and Definitions of Non-GAAP Financial Measures" below for additional information.

Otis Worldwide Narrows FY24 Outlook: Adj EPS From $3.85-$3.90 to $3.85 vs $3.87 Est; Sales from $14.30B-$14.50B to $14.20B vs $14.42B Est

Lindberg replaces RJ Sheedy, who has stepped down from his position and resigned from the Company's Board of Directors. The Board has engaged a global executive search firm to begin the process of identifying a permanent CEO.

Management

Grocery Outlet Names Eric Lindberg, Current Chairman Of The Board, As Interim President And CEO, Effective Immediately

ALLETE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALE#NYSE">ALE</a>) reported quarterly earnings of $0.78 per share which missed the analyst consensus estimate of $0.93 by 16.13 percent. This is a 47.65 percent decrease over earnings of $1.49 per share from the same period last year. The company reported quarterly sales of $407.20 million which beat the analyst consensus estimate of $391.00 million by 4.14 percent. This is a 7.50 percent increase over sales of $378.80 million the same period last year.

Earnings Beats

Earnings Misses

ALLETE Q3 EPS $0.78 Misses $0.93 Estimate, Sales $407.20M Beat $391.00M Estimate

Cleveland-cliffs Announced That It Has Received Regulatory And Program Approvals Under The Investment Canada Act And Strategic Innovation Fund, The Final Approvals Needed To Complete Pending Acquisition Of Stelco Holdings Inc.

In Agribusiness, full-year results are forecasted to be up slightly from our previous outlook, reflecting the better than expected third quarter, but down compared to last year.
In Refined and Specialty Oils, full-year results are expected to be up from our previous outlook, but down compared to last year's record performance.
In Milling, full-year results are expected to be down from our previous outlook reflecting the lower than expected third quarter, but up from last year.
In Corporate and Other, full-year results are expected to be similar to our previous outlook.
In Non-Core, full-year results are expected to be down considerably from our previous outlook due to the lower than expected third quarter and the loss of income from the sale of our ownership in the joint venture, which closed on October 1, 2024.
Additionally, the Company currently expects the following for 2024: an adjusted annual effective tax rate range of 22% to 24%; net interest expense in the range of $285 to $305 million; capital expenditures in the upper end of the range of $1.2 to $1.4 billion; and depreciation and amortization of approximately $450 million.

Bunge Reiterates FY24 Adjusted EPS Outlook Of At Least $9.25 Vs. $9.41 Estimate; In Agribusiness Results Are Forecasted To Be Up Slightly But Down Compared To Last Year

The Company expects full-year reported and organic revenue growth of approximately 11 percent.
•The Company expects GAAP and adjusted continuing EPS for full-year 2024 of approximately $11.10.

Trane Technologies Raises FY24 Organic Revenue Growth Outlook To 11% (From 10%); Adj EPS Outlook To $11.10 (From $10.80) Vs. $10.09 Est.

Beginning in fiscal 2025, the company will have two reportable segments – Transportation Solutions and Industrial Solutions – resulting from a reorganization announced in the fourth quarter of fiscal 2024. The company will also provide recast financial information in an 8-K filing later this quarter.

From FY25 TE Connectivity Will Have 2 Reportable Segments, Transportation Solutions and Industrial Solutions Under Latest Reorganization

Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $0.97 by 1.03 percent. This is a 1.05 percent increase over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $3.548 billion which missed the analyst consensus estimate of $3.587 billion by 1.10 percent. This is a 0.71 percent increase over sales of $3.523 billion the same period last year.

Otis Worldwide Q3 2024 Adj. EPS $0.96 Misses $0.97 Estimate, Sales $3.548B Miss $3.587B Estimate

ZC SP ETN REDEEM 28/06/2041 USD 25 - 063679583

Comments

MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN

Interés en corto

MicroSectors Oil & Gas Exp. & Prod. 3x Leveraged ETN (ARCA:OILU), Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL